NCT00088114View on ClinicalTrials.gov

STA-4783 and Paclitaxel for Treatment of Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Neoplasms
Interventions
DRUG

STA-4783/paclitaxel

Trial Locations (2)

02215

Beth Israel-Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Synta Pharmaceuticals Corp.

INDUSTRY

NCT00088114 - STA-4783 and Paclitaxel for Treatment of Solid Tumors | Biotech Hunter | Biotech Hunter